423 related articles for article (PubMed ID: 31332440)
1. Advances in gene therapy for cystic fibrosis lung disease.
Yan Z; McCray PB; Engelhardt JF
Hum Mol Genet; 2019 Oct; 28(R1):R88-R94. PubMed ID: 31332440
[TBL] [Abstract][Full Text] [Related]
2. Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis.
King NE; Suzuki S; Barillà C; Hawkins FJ; Randell SH; Reynolds SD; Stripp BR; Davis BR
Hum Gene Ther; 2020 Sep; 31(17-18):956-972. PubMed ID: 32741223
[TBL] [Abstract][Full Text] [Related]
3. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
Jiang Q; Engelhardt JF
Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
[TBL] [Abstract][Full Text] [Related]
4. Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.
Tang Y; Yan Z; Engelhardt JF
Hum Gene Ther; 2020 May; 31(9-10):524-537. PubMed ID: 32138545
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.
Copreni E; Penzo M; Carrabino S; Conese M
Gene Ther; 2004 Oct; 11 Suppl 1():S67-75. PubMed ID: 15454960
[TBL] [Abstract][Full Text] [Related]
6. Transduction of Pig Small Airway Epithelial Cells and Distal Lung Progenitor Cells by AAV4.
Chen OG; Mather SE; Brommel CM; Hamilton BA; Ehler A; Villacreses R; Girgis RE; Abou Alaiwa M; Stoltz DA; Zabner J; Li X
Cells; 2021 Apr; 10(5):. PubMed ID: 33923029
[TBL] [Abstract][Full Text] [Related]
7. Genetic therapies for cystic fibrosis lung disease.
Sinn PL; Anthony RM; McCray PB
Hum Mol Genet; 2011 Apr; 20(R1):R79-86. PubMed ID: 21422098
[TBL] [Abstract][Full Text] [Related]
8. Widespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac/adenovirus.
Cooney AL; Singh BK; Loza LM; Thornell IM; Hippee CE; Powers LS; Ostedgaard LS; Meyerholz DK; Wohlford-Lenane C; Stoltz DA; B McCray P; Sinn PL
Nucleic Acids Res; 2018 Oct; 46(18):9591-9600. PubMed ID: 30165523
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
10. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
11. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies.
Rubenstein RC
Mol Diagn Ther; 2006; 10(5):293-301. PubMed ID: 17022692
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease.
Marquez Loza LI; Yuen EC; McCray PB
Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30875857
[TBL] [Abstract][Full Text] [Related]
14. Genetic therapies in cystic fibrosis.
Taylor-Cousar JL; Boyd AC; Alton EWFW; Polineni D
Curr Opin Pulm Med; 2023 Nov; 29(6):615-620. PubMed ID: 37700667
[TBL] [Abstract][Full Text] [Related]
15. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
16. Single-dose lentiviral gene transfer for lifetime airway gene expression.
Stocker AG; Kremer KL; Koldej R; Miller DS; Anson DS; Parsons DW
J Gene Med; 2009 Oct; 11(10):861-7. PubMed ID: 19634193
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral gene transfer corrects the ion transport defect in the sinus epithelia of a porcine CF model.
Potash AE; Wallen TJ; Karp PH; Ernst S; Moninger TO; Gansemer ND; Stoltz DA; Zabner J; Chang EH
Mol Ther; 2013 May; 21(5):947-53. PubMed ID: 23511247
[TBL] [Abstract][Full Text] [Related]
18. Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis.
Schneider-Futschik EK
Gene Ther; 2019 Sep; 26(9):354-362. PubMed ID: 31300729
[TBL] [Abstract][Full Text] [Related]
19. Emerging gene therapies for cystic fibrosis.
Miah KM; Hyde SC; Gill DR
Expert Rev Respir Med; 2019 Aug; 13(8):709-725. PubMed ID: 31215818
[No Abstract] [Full Text] [Related]
20. [On the way to gene therapy in cystic fibrosis].
Norek A; Bal J
Med Wieku Rozwoj; 2006; 10(1 Pt 2):247-74. PubMed ID: 17028392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
